CD14 and systemic lupus erythematosus: There are reports of an expansion of CD14+CD16+ monocytes or reduced percentages of CD14lowCD16+ monocytes in SLE patients compared to healthy controls, while other researchers reported that there is no significant difference in the percentages of the three subsets of monocytes between SLE patients and healthy individuals (5, 7–9).